ANRS | Emerging Infectious Diseases, an autonomous agency of Inserm, supports research to provide scientific responses to infectious diseases in times of crisis and over the long term.
Dernière mise à jour le 21 July 2023
Successor to the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) – founded to respond to the urgency and extent of the HIV/AIDS epidemic – and to the Inserm REACTing consortium, ANRS | Emerging Infectious Diseases was created on 1 January 2021.
We facilitate, coordinate, evaluate and fund research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis, and emerging and re-emerging infectious diseases such as COVID-19, viral haemorrhagic fevers and arboviruses.
We cover all areas of research: basic, translational, clinical, public health and the human and social sciences.
Under the supervision of the French Ministries of Higher Education and Research and Health and Prevention, our agency federates an inter-institutional network of national and international doctors and researchers, patient associations and civil society representatives, with their full integration within our governance and operations. This co-construction dynamic guarantees that the projects we implement are in line with the expectations of the communities concerned, with the aim of limiting the health, economic and social impacts of epidemics.
We are developing a global health approach according to One Health principles, which concern the links between human health, animal health and the environment, thereby reinforcing France’s response in the event of a crisis. Our agency is part of an international effort particularly in close conjunction with Europe and with a network of partners in low- and middle-income countries to fight against combat epidemics.